Abstract:Objectives The purpose of this qualitative study is to describe the acceptability and appropriateness of continuous glucose monitoring (CGM) in people living with type 1 diabetes (PLWT1D) at first-level (district) hospitals in Malawi. Design We conducted semistructured qualitative interviews among PLWT1D and healthcare providers participating in the study. Standardised interview guides elicited perspectives on the appropriateness and acceptability of CGM use for PLWT1D and their providers, and provider perspectives on the effectiveness of CGM use in Malawi. Data were coded using Dedoose software and analysed using a thematic approach. Setting First-level hospitals in Neno district, Malawi. Participants Participants were part of a randomised controlled trial focused on CGM at first-level hospitals in Neno district, Malawi. Pretrial and post-trial interviews were conducted for participants in the CGM and usual care arms, and one set of interviews was conducted with providers. Results Eleven PLWT1D recruited for the CGM randomised controlled trial and five healthcare providers who provided care to participants with T1D were included. Nine PLWT1D were interviewed twice, two were interviewed once. Of the 11 participants with T1D, six were from the CGM arm and five were in usual care arm. Key themes emerged regarding the appropriateness and effectiveness of CGM use in lower resource setting. The four main themes were (a) patient provider relationship, (b) stigma and psychosocial support, (c) device usage and (d) clinical management. Conclusions Participants and healthcare providers reported that CGM use was appropriate and acceptable in the study setting, although the need to support it with health education sessions was highlighted. This research supports the use of CGM as a component of personalised diabetes treatment for PLWT1D in resource constraint settings. Trial registration number PACTR202102832069874; Post-results.

What problem does this paper attempt to address?

This paper aims to explore the applicability and acceptance of continuous glucose monitoring (CGM) among people living with type 1 diabetes (PLWT1D) in rural primary hospitals in Malawi. Specifically, the study evaluated the feasibility of using CGM in a resource - limited setting, the acceptance of patients and healthcare providers, and how this technology affects patients' self - management ability and the doctor - patient relationship through qualitative methods. ### Research Background Type 1 diabetes is an endocrine disease, affecting approximately 8,746,562 people globally, of which 1,665,997 people live in low - and lower middle - income countries (LLMICs). Type 1 diabetes requires careful management as it can lead to many long - term life - threatening complications. It is a lifelong disease and requires uninterrupted access to insulin and blood - glucose - monitoring tools to survive. By 2040, it is expected that 13.5 to 17.5 million people will have type 1 diabetes, and the regions with the largest growth will be LLMICs. In addition, the premature mortality rate of people with type 1 diabetes in LLMICs may be nine times that in high - income countries (HICs). ### Research Objectives The main objective of this study was to describe, through qualitative research, the acceptance and applicability of continuous glucose monitoring among people with type 1 diabetes in rural primary hospitals in Malawi. The study design included semi - structured qualitative interviews with people with type 1 diabetes and healthcare providers to collect their views on the appropriateness and acceptance of CGM use, as well as the views of healthcare providers on the effectiveness of CGM use in Malawi. ### Methods The study was conducted in Neno District Hospital and Lisungwi Community Hospital in Malawi. These hospitals are operated by the Ministry of Health (MoH) and supported by the US non - government organization Partners In Health (PIH). The study subjects included people with type 1 diabetes participating in a randomized controlled trial (RCT) and their healthcare providers. Participants were randomly assigned to the CGM group or the routine care group. The study collected data through semi - structured interviews and used Dedoose software for data coding and thematic analysis. ### Results The study found that participants and healthcare providers considered the use of CGM in the study setting to be appropriate and acceptable, but emphasized the need to support its use through health education courses. This study supports the use of CGM as part of personalized diabetes treatment in resource - constrained settings. ### Main Conclusions Participants and healthcare providers reported that the use of CGM in the study setting was appropriate and acceptable, although it needed to be supported by health education meetings. This study supports the use of CGM as part of personalized diabetes treatment in resource - constrained settings.

Appropriateness and acceptability of continuous glucose monitoring in people with type 1 diabetes at rural first-level hospitals in Malawi: a qualitative study

Feasibility of continuous glucose monitoring in patients with type 1 diabetes at two district hospitals in Neno, Malawi: a randomised controlled trial

Continuous glucose monitoring for primary care patients with diabetes: Barriers, facilitators, & resources to support access

Mixed methods study on the feasibility of implementing periodic continuous glucose monitoring among individuals with type 2 diabetes mellitus in a primary care setting

Technology and Continuous Glucose Monitoring Access, Literacy, and Use Among Patients at the Diabetes Center of an Inner-City Safety-Net Hospital: Mixed Methods Study

Health literacy of patients using continuous glucose monitoring

Exploring the Initial Encounter with Continuous Glucose Monitoring among Individuals with Type 2 Diabetes: A Two-Week Trip

Clinician-Reported Barriers and Needs for Implementation of Continuous Glucose Monitoring

Implementation research: a protocol for two three-arm pragmatic randomised controlled trials on continuous glucose monitoring devices in people with type 1 diabetes in South Africa and Kenya

User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries: a qualitative study in Kyrgyzstan, Mali, Peru and Tanzania

Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin

Identifying the deficiencies of currently available CGM to improve uptake and benefit

The effectiveness of continuous glucose monitoring with remote telemonitoring-enabled virtual educator visits in adults with non-insulin dependent type 2 diabetes: A randomized trial

Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives

Innovative solution or cause for concern? The use of continuous glucose monitors in people not living with diabetes: A narrative review

Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study

Effectiveness and acceptability of continuous glucose monitoring for type 2 diabetes management: A narrative review

Continuous glucose monitoring among nurse practitioners in primary care: Characteristics associated with prescribing and resources needed to support use

Integration of Flash Glucose Monitoring During the Transition of Care From Inpatient to Outpatient Settings in Patients With Type 2 Diabetes

Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized Controlled Trial

Study protocol: Safety and efficacy of smart watch integrated do-it-yourself continuous glucose monitoring in adults with Type 1 diabetes, a randomised controlled trial